Exosomal miR-136-5p Derived from Anlotinib-Resistant NSCLC Cells Confers Anlotinib Resistance in Non-Small Cell Lung Cancer Through Targeting PPP2R2A
Guoqing Gu,1,* Chenxi Hu,1,* Kaiyuan Hui,1 Huiqin Zhang,1 Ting Chen,1 Xin Zhang,2 Xiaodong Jiang1 1Department of Oncology, The Affiliated Lianyungang Hospital of Xuzhou Medical University, Lianyungang, Jiangsu, 222000, People’s Republic of China; 2Lianyungang Clinical College of Nanj...
Enregistré dans:
| Auteurs principaux: | , , , , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Dove Medical Press
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/40ea827694da4063ae886ee12768c438 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|